GALECTIN THERAPEUTICS INC - COM NEW (GALT)

CUSIP: 363225202

Q2 2024 13F Holders as of 30 Jun 2024

Share change
+1,785,838
Put/Call ratio
0.28%
SEC-reported price per share
$2.26
Number of holders
71
Value change
+$4,010,257
Number of buys
39
Open additional details 1 more signal available
Number of sells
18

Security key

363225202

Report period

Q2 2024

Institutions

71

Top holders

10

Ownership snapshot

Top reported holders of GALT - GALECTIN THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F Highest disclosed value: $4,731,939 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $4.73M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $4.73M
OSAIC HOLDINGS, INC. $3.02M
BlackRock Finance, Inc. $1.7M
GEODE CAPITAL MANAGEMENT, LLC $1.36M
Geneos Wealth Management Inc. $977.2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
class O/S missing
$4,731,939
1,979,891 shares
31 Mar 2024
OSAIC HOLDINGS, INC.
13F
Company
13F
class O/S missing
$3,022,949
1,264,845 shares
31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
class O/S missing
$1,703,204
712,638 shares
31 Mar 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
class O/S missing
$1,355,791
567,161 shares
31 Mar 2024
Geneos Wealth Management Inc.
13F
Company
13F
class O/S missing
$977,152
408,850 shares
31 Mar 2024
Wealthspire Advisors, LLC
13F
Company
13F
class O/S missing
$952,114
398,374 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
71
Shares
9,417,077
Rows available
71
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
57
Q2 2024 holders
71
Holder diff
14
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .